Related Experiment Videos

A study of metalloproteinases in fifty joint fluid specimens

P Gaudin1, M Razakaboay, A Surla

  • 1Rheumatology Department, Michallon Teaching Hospital, Grenoble, France.

Revue Du Rhumatisme (English Ed.)
|June 1, 1997
PubMed
Abstract

Insights

Matrix metalloproteinase-9 (MMP-9), tissue inhibitor of metalloproteinases-1 (TIMP-1), and matrix metalloproteinase-3 (MMP-3) levels differ significantly between inflammatory and mechanical joint fluids. These findings highlight distinct biomarkers for joint conditions.

Area of Science:

  • Biochemistry
  • Rheumatology
  • Molecular Biology

Background:

  • Joint fluid analysis is crucial for diagnosing joint disorders.
  • Matrix metalloproteinases (MMPs) and their inhibitors play roles in joint pathology.

Purpose of the Study:

  • To investigate the concentrations and activity of specific gelatinases (MMP-2, MMP-9), TIMP-1, and MMP-3 in synovial fluid.
  • To differentiate these protein levels between mechanical and inflammatory joint conditions.

Main Methods:

  • Synovial fluid specimens were analyzed for protein levels, cell counts, and crystal presence.
  • Quantitative zymography assessed gelatinolytic activity.
  • ELISA was used to quantify TIMP-1 and MMP-3 levels.

Main Results:

  • Activated MMP-2 was present in all samples, with no group differences.
  • MMP-9 was found predominantly in an inactive form.
  • Elevated levels of MMP-9, TIMP-1, and MMP-3 were observed in inflammatory joint fluids compared to mechanical ones.
  • MMP-9 and TIMP-1 levels correlated with neutrophil counts and C-reactive protein in rheumatoid arthritis patients.

Conclusions:

  • Synovial fluid levels of MMP-9, TIMP-1, and MMP-3 exhibit significant differences between inflammatory and mechanical joint disorders.
  • These MMPs and TIMP-1 may serve as potential biomarkers for distinguishing joint pathologies.

Related Concept Videos